Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2 Positive Breast Cancer 1 Breast Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × HER2 Positive Breast Cancer × pyrotinib × Clear all

NCT06958627 2025-05-06

any

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2/3 Recruiting

HER2 Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡